Subscribe to RoboticOncology.com RSS Feed

Prostate Cancer Risk Increases With Vitamin E and Selenium Supplements

NEW YORK, NY--(Marketwired - Apr 15, 2014) - The Selenium and Vitamin E Cancer Prevention Trial (SELECT) began 13 years ago under the hypothesis that selenium and vitamin E supplements could aid in reducing prostate cancer risk. Contrary to anticipated results, the long-term study demonstrated that high doses of each supplement, whether taken alone or together, actually increased a man's risk of developing prostate cancer.

"Once believed to prevent prostate cancer, these two supplements are now understood to pose a potential threat to some men," said David Samadi, robotic prostate surgery expert and Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital. "The results are a cautionary tale about adding supplements or unusual dietary changes without the counsel of a medical professional."

The SELECT study began in 2001 and included more than 35,000 men across 400 healthcare sites in the United States, Puerto Rico, and Canada. Seven years into the study, researchers reported no positive associations between prostate cancer prevention and vitamin E or selenium and instructed all participants to cease intake.

In 2011, researchers reported that men who took vitamin E alone for an average of 5.5 years had a 17 percent increased risk of developing prostate cancer. The results were documented at a follow-up of 1.5 years after participants stopped taking the supplements. Increased prostate cancer risk was also seen among men taking selenium alone and in conjunction with vitamin E -- as much as 91 percent -- in cases where selenium status was high at treatment initiation.

"From this data, researchers extrapolate that men over 65 who opt to take vitamin E supplements may face similarly increased rates of prostate cancer risk," explained Dr. Samadi. "This isn't to say that men should avoid vitamin E, particularly as part of a multi-vitamin regimen. Rather, men are encouraged to talk with their providers about prostate cancer risk factors and the necessity of supplements before taking them."

SELECT study participants were given 400 IU of Vitamin E per day and/or 200 mcg of selenium per day. More can be learned about the SELECT study in the publishing findings in the Journal of the National Cancer Institute, http://jnci.oxfordjournals.org/content/106/3/djt456.abstract?sid=f1e399bb-639e-4964-97bd-71306668777b. The study timeline is also detailed on the National Cancer Institute website, 

Back to Press Releases


Bookmark Using:
Facebook Twitter LinkedIn Email Yahoo

Share on Facebook

Call to Make an Appointment With Dr. David Samadi:

1-212-365-5000

Click the contact link to learn how Dr. Samadi can help treat your prostate cancer and give you back your quality of life.

* The benefits of robotic surgery cannot be guaranteed as surgery is both patient and procedure specific. Previous surgical results do not guarantee future outcomes.




Testimonials
William and Glenn, USA

In May of 2010 my brother Glenn was suffering from back pain. After tests for kidney stones were negative it was discovered that his PSA level was 9.

more..
MvR, Netherlands (Translated)

After the shock of being diagnosed with cancer, my next step was to find the best doctor to remove the prostate. I found Dr. Samadi, and he and his team did a great job of patient in-take and supporting me practically and emotionally through the process.

more..
B. Koenig, USA

Again, on behalf of myself and my family, I just want to thank you for your compassion, capableness and concern during this difficult time. As a result of having had a Robotic Laparoscopic Prostatectomy I can now look forward to a long and cancer-free life.

more..
J.W.W., USA

Dr. Samadi made it very clear as to his vision of me being cancer free and at the same time he considers quality of life as being extremely important. He portrayed these feelings with a real sense of commitment and confidence. I felt as if he directly spoke to me in a confident and understanding manner.

more..